These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6680328)

  • 1. Changes in plasma levels of protease inhibitors to the degree of metastasis and prognosis of gastric cancer.
    Kageyama T; Oyabu H; Tsumoto S; Ohshiba S
    Bull Osaka Med Sch; 1983 Oct; 29(2):69-84. PubMed ID: 6680328
    [No Abstract]   [Full Text] [Related]  

  • 2. Protease inhibitor and gastric cancer.
    Tsumoto S; Oyabu H; Kageyama T
    Bull Osaka Med Sch; 1983 Jul; 29(1):18-26. PubMed ID: 6204707
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
    Kageyama T; Oyabu H; Ohshiba S
    Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral and gastric fibrinolysis in patients with gastric carcinoma.
    Prokopowicz J; Gabryelewicz A; Wołosowicz N; Szałaj W; Puchalski Z
    Z Exp Chir; 1975; 8(5):309-12. PubMed ID: 1053190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
    Kwon HC; Oh SY; Lee S; Kim SH; Han JY; Koh RY; Kim MC; Kim HJ
    Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor.
    Lee JH; Ryu KW; Kim S; Bae JM
    Hepatogastroenterology; 2004; 51(60):1860-3. PubMed ID: 15532844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
    Gao ZL; Zhang C; Du GY; Lu ZJ
    Hepatogastroenterology; 2007; 54(77):1591-5. PubMed ID: 17708308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and histological studies on the prognosis of gastric cancer in Osaka Kosei-Nenkin Hospital in the last 13 years].
    Murakami E; Nagatomo T; Hori K; Asano N; Shirai T
    Gan No Rinsho; 1967 Dec; 13(12):1094-103. PubMed ID: 5628104
    [No Abstract]   [Full Text] [Related]  

  • 9. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer--can it be a marker for malignant gastric lesions?
    Aliustaoglu M; Yumuk PF; Gumus M; Ekenel M; Bolukbas F; Bolukbas C; Mutlu N; Basaran G; Avsar E; Turhal NS
    Acta Oncol; 2004; 43(8):770-1. PubMed ID: 15764225
    [No Abstract]   [Full Text] [Related]  

  • 11. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(6B):4489-93. PubMed ID: 11205293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteinase inhibitors as markers of stomach cancer].
    Beliaev MV; Zorin NA; Chinchenkov MI
    Vopr Onkol; 1996; 42(4):30-1. PubMed ID: 8928454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients.
    Choi JH; Oh JY; Ryu SK; Kim SJ; Lee NY; Kim YS; Yi SY; Shim KS; Han WS
    Cancer; 1997 May; 79(10):1879-83. PubMed ID: 9149012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer.
    Gadducci A; Marrai R; Baicchi U; Ferdeghini M; Fanucchi A; Facchini V; Genazzani AR
    Anticancer Res; 1995; 15(6B):2683-6. PubMed ID: 8669847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of urokinase-type plasminogen activator and its inhibitor PAI-1 in gastric cancer.
    Herszényi L; Plebani M; Cardin R; Carraro P; De Paoli M; Roveroni G; Naccarato R; Farinati F
    Acta Physiol Hung; 1995; 83(3):213-21. PubMed ID: 8852646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer.
    Yamashita H; Kitayama J; Nagawa H
    Jpn J Clin Oncol; 2005 Oct; 35(10):595-600. PubMed ID: 16186176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers.
    Herszényi L; István G; Cardin R; De Paoli M; Plebani M; Tulassay Z; Farinati F
    Eur J Cancer Prev; 2008 Oct; 17(5):438-45. PubMed ID: 18714186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New prognostic factors in gastric cancer].
    Herszényi L
    Orv Hetil; 1999 Aug; 140(32):1771-7. PubMed ID: 10489759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.